All Stories

  1. Efficacy and Safety of Pitavastatin in Children and Adolescents at High Future Cardiovascular Risk
  2. Gonadal steroids, gonadotropins and DHEAS in young adults with familial hypercholesterolemia who had initiated statin therapy in childhood
  3. Early initiation of statin treatment in children with familial hypercholesterolaemia
  4. Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
  5. RETRACTED: Design of a Phase 3, Double-Blind, Randomized Trial of Lomitapide vs. Placebo in Pediatric Patients with Homozygous Familial Hypercholesterolemia
  6. Long-Term Statin Treatment in Children with Familial Hypercholesterolemia: More Insight into Tolerability and Adherence
  7. Ten-Year Follow-up After Initiation of Statin Therapy in Children With Familial Hypercholesterolemia
  8. Statins for children with familial hypercholesterolemia
  9. EFFICACY AND SAFETY OF ROSUVASTATIN THERAPY FOR CHILDREN AND ADOLESCENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA: RESULTS FROM THE CHARON STUDY
  10. EFFECT OF ROSUVASTATIN THERAPY ON ARTERIAL WALL CHANGES IN CHILDREN AND ADOLESCENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA: RESULTS FROM THE CHARON STUDY
  11. HOMOZYGOUS AUTOSOMAL DOMINANT HYPERCHOLESTEROLEMIA IN THE NETHERLANDS: PREVALENCE, GENOTYPE-PHENOTYPE RELATIONSHIP AND CLINICAL OUTCOME
  12. Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation
  13. Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation
  14. Management of Hypercholesterolemia in Children
  15. Design and baseline data of a pediatric study with rosuvastatin in familial hypercholesterolemia
  16. Statin therapy and secretory phospholipase A2 in children with heterozygous familial hypercholesterolemia
  17. Familial Hypercholesterolemia: Advances in Understanding the Early Natural History
  18. Follow-Up of Children Diagnosed with Familial Hypercholesterolemia in a National Genetic Screening Program
  19. Drug Therapy of Hypercholesterolaemia in Children and Adolescents
  20. Statin use during pregnancy: a systematic review and meta-analysis
  21. Lipoprotein-associated phospholipase A2 mass and activity in children with heterozygous familial hypercholesterolemia and unaffected siblings: Effect of pravastatin
  22. Treatment of dyslipidaemia in childhood
  23. Efficacy and Safety of Rosuvastatin Therapy for Children With Familial Hypercholesterolemia
  24. Familial Dyslipidaemia in Children
  25. Predictive genetic testing for cardiovascular diseases: Impact on carrier children
  26. Atherogenic Lipoprotein Particle Size and Concentrations and the Effect of Pravastatin in Children with Familial Hypercholesterolemia
  27. Health-related quality of life of children with a positive carrier status for inherited cardiovascular diseases
  28. Effect of aging and obesity on the expression of dyslipidaemia in children from families with familial combined hyperlipidaemia
  29. Paraoxonase genotype and carotid intima???media thickness in children with familial hypercholesterolemia
  30. Oxidized Low-Density Lipoprotein in Children With Familial Hypercholesterolemia and Unaffected Siblings
  31. Plant stanols do not restore endothelial function in pre-pubertal children with familial hypercholesterolemia despite reduction of low-density lipoprotein cholesterol levels
  32. Effect of low-density lipoprotein receptor mutation on lipoproteins and cardiovascular disease risk: a parent–offspring study
  33. HT03-IS-002 Familial hypercholesterolemia in children
  34. Efficacy and Safety of Statin Therapy in Children With Familial Hypercholesterolemia
  35. Steady-State Pharmacokinetics of Pravastatin in Children with Familial Hypercholesterolaemia
  36. Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia
  37. The Apolipoprotein ε4 Allele Confers Additional Risk in Children with Familial Hypercholesterolemia
  38. Family History and Cardiovascular Risk in Familial Hypercholesterolemia: Data in More Than 1000 Children
  39. Surrogate markers of atherosclerosis: impact of statins
  40. Vetstofwisselingsafwijkingen bij kinderenfamiliaire hypercholesterolemie cholesterol